In September 2025, Amex submitted the permit application for the bulk sample program. Subject to permitting and regulatory approvals, the Company is targeting the commencement of bulk sample ...
Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results